MentorcliQ, brand name or equal.
ID: 75F40125Q00102Type: Sources Sought
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFFOOD AND DRUG ADMINISTRATIONFDA OFFICE OF ACQ GRANT SVCSBeltsville, MD, 20705, USA

Original Source

https://sam.gov/opp/6b6bb3369cc64d94969993babb9260f2/view
Timeline
    Description

    The Department of Health and Human Services, specifically the Food and Drug Administration (FDA), is seeking small businesses capable of providing Commercial Off-the-Shelf software licenses for MentorcliQ or equivalent solutions through a Request for Information (RFI). The FDA aims to enhance its mentoring program by acquiring a SaaS cloud-based platform that is interoperable with Google Cloud, supports single sign-on, accommodates up to 19,000 users, and complies with Section 508 accessibility standards. This RFI is intended for information and market research purposes only and does not constitute a solicitation or contract award; responses must be submitted by January 20, 2025, to Min Jie Zeng at minjie.zeng@fda.hhs.gov and Lilibeth Deato at Lilibeth.Deato@fda.hhs.gov.

    Point(s) of Contact
    Min Jie Zeng
    minjie.zeng@fda.hhs.gov
    Files
    Title
    Posted
    RFI instruction and attachement (v1).pdf
    The Food and Drug Administration (FDA) has issued a Request for Information (RFI) aimed at identifying small businesses qualified to provide Commercial Off-the-Shelf software licenses for MentorcliQ or equivalent solutions. This RFI serves solely for information and market research; it is not a solicitation or contract award. Interested small businesses are invited to submit detailed responses by January 20, 2025, outlining their capabilities, experience, and suggestions regarding the Draft Statement of Work. Key requirements include a SaaS cloud-based platform interoperable with Google Cloud, single sign-on capabilities, extensive user support, and compliance with Section 508 accessibility standards. The contractor must accommodate up to 19,000 users and facilitate an automated mentoring match process, alongside providing maintenance, training, and detailed reporting functionalities. Responses must include organizational details and a demonstration of relevant experience. The stated deliverables encompass a license for MentorcliQ for a specified duration, maintenance support, and training, emphasizing the FDA’s commitment to enhancing its mentoring program through reliable and effective software solutions. The RFI is structured to gather comprehensive insights to inform potential future procurements, highlighting the importance of small business contributions in governmental service delivery.
    Lifecycle
    Title
    Type
    MentorcliQ, brand name or equal.
    Currently viewing
    Sources Sought
    Similar Opportunities
    PRIMO Software Licensing
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Food and Drug Administration (FDA), is seeking qualified small businesses to provide PRIMO Software Licensing and Maintenance Support Services. The procurement involves supplying 21 PRIMO software licenses for a base year, with two additional option years, to ensure the continuous operation of the FDA's CFSAN CAEMS system. This software is crucial for pharmacovigilance and regulatory compliance, enhancing the FDA's capabilities in monitoring food safety. Interested parties must submit their quotes by August 26, 2024, and are encouraged to contact Roosevelt Walker at roosevelt.walker@fda.hhs.gov for further details. The contract will be awarded as a firm-fixed-price purchase order, emphasizing compliance with federal acquisition regulations and accessibility standards.
    Access to Outpatient Longitudinal Drug Utilization Data
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Food and Drug Administration (FDA), is seeking qualified small businesses to provide access to outpatient longitudinal drug utilization data through a Sources Sought notice. The primary objective is to acquire existing, HIPAA-compliant data resources that will enhance drug safety evaluations, support post-market surveillance, and inform regulatory decisions, rather than developing new databases. This initiative is crucial for monitoring medication utilization trends, particularly in areas such as opioid surveillance, and aims to improve public health outcomes through rigorous analyses of drug safety data. Interested firms must submit their responses by January 23, 2025, including their business size status and DUNS number, and can direct inquiries to Telisha Wilson at telisha.wilson@fda.hhs.gov.
    Milliflex Rapid 2.0
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Food and Drug Administration (FDA), is seeking responses for a Sources Sought Notice regarding the acquisition of the Milliflex Rapid 2.0 microbial detection system. This procurement aims to enhance quality control testing for bioburden contamination in pharmaceutical products, necessitating a system that is compatible with the existing Milliflex Oasis filtration pump currently in use. The initiative is critical for ensuring compliance with quality control standards in pharmaceutical manufacturing, thereby bolstering the FDA's capabilities in evaluating rapid microbial detection methods. Interested vendors must submit their responses by January 30, 2024, at 12:00 PM ET, directed to Contract Specialist Iris Johnson at Iris.Johnson1@fda.hhs.gov and Contracting Officer Maria Finan at Linda.Finan@fda.hhs.gov.
    FY25 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Food and Drug Administration (FDA), is soliciting proposals through the FY25 Broad Agency Announcement (BAA) aimed at advancing regulatory science and innovation. This opportunity invites organizations, particularly small businesses, to submit research and development proposals that address critical areas such as alternative drug development methods, advanced manufacturing technologies, and predictive toxicology, with a strong emphasis on including diverse populations in research. Proposals must be submitted by February 24, 2025, and will undergo a two-tier evaluation process, with the potential for multiple contracts awarded based on proposal quality and funding availability. Interested parties can contact Ian Weiss at Ian.Weiss@fda.hhs.gov or by phone at 301-796-5728 for further information.
    FDA Move and Labor Services Recompete
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Food and Drug Administration (FDA), is seeking qualified certified 8(a) small business firms to provide Move and Labor Services under an Indefinite Delivery Indefinite Quantity (IDIQ) contract. The primary objective is to assist over 14,000 personnel in the National Capital Region with various moving activities, including specialized laboratory and IT relocations, document destruction, and warehouse management. This initiative is crucial for maintaining operational efficiency and secure handling of sensitive materials within the FDA. Interested firms must submit their responses by January 23, 2025, to Sheneil Green at Sheneil.Green@fda.hhs.gov, with further details outlined in the attached Statement of Work.
    Solicitation: Tobacco Retailer Inspections - 75F40125R00018
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the Food and Drug Administration (FDA), is soliciting proposals for the Tobacco Retailer Inspections contract (75F40125R00018), aimed at conducting compliance check inspections across multiple regions in the United States. The primary objective of this procurement is to ensure adherence to federal laws regarding the sale and advertising of tobacco products, particularly focusing on preventing youth access to these products. This contract will involve the award of multiple Indefinite Delivery/Indefinite Quantity (IDIQ) contracts, with a total contract period of five years, and will require contractors to employ commissioned inspectors and underage purchasers for effective inspections. Interested parties must submit their proposals by February 4, 2025, at 2:00 PM EST, and can direct inquiries to Janice Heard at janice.heard@fda.hhs.gov or Brandon Rafus at brandon.rafus@fda.hhs.gov.
    Request for Information--Medical Calculators SaaS
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is issuing a Request for Information (RFI) to gather capabilities from firms regarding the integration of third-party Clinical Decision Support (CDS) applications, specifically medical calculators, into clinical workflows aimed at improving health outcomes for veterans. The initiative seeks detailed responses about technical solutions and capabilities, particularly from firms offering Software as a Service (SaaS) solutions, with an emphasis on cloud infrastructure, scalability, and compliance with federal standards such as FedRAMP. Responses to this RFI are due by January 31, 2025, and interested parties should contact William Milline or Cristine Carmody via email for further information.
    NOTICE OF INTENT TO SOLE SOURCE - QUADRUPOLE-ORBITRAP HIGH RESOLUTION MASS SPECTROMETER WITH LIQUID CHROMATOGRAPH
    Health And Human Services, Department Of
    The U.S. Food and Drug Administration (FDA) intends to award a sole-source contract for a benchtop quadrupole-Orbitrap™ high-resolution mass spectrometer (HRMS) with liquid chromatograph to Thermo Electron North America LLC. This specialized equipment is crucial for developing and validating methods to detect chemical residues and contaminants in food, including mycotoxins, pesticides, and veterinary drugs. The unique capabilities of the Thermo Electron instrument are necessary to meet the FDA's requirements for timely and accurate identification of contaminants in complex food samples, which is vital for ensuring food safety. Interested parties must submit a capability statement by January 27, 2025; however, if no viable responses are received, the contract will proceed without competition. For further inquiries, contact Erika Crawford at erika.crawford@fda.hhs.gov or call 301-796-0298.
    FDA - Notice of Intent to Sole Source -Biosimilar Education for Patients and Healthcare Providers: Medscape and WebMD
    Health And Human Services, Department Of
    The Food and Drug Administration (FDA) intends to make a sole source award to WebMD Health Corp. for the development and provision of "Biosimilar Education for Patients and Healthcare Providers." This initiative aims to create accredited continuing education content for healthcare providers, including doctors, pharmacists, and nurses, focusing on biosimilars and interchangeable products, covering their development, regulatory review, clinical outcomes, and practical applications. The educational effort is crucial for enhancing clinical competency among providers, thereby increasing their confidence in prescribing and using biosimilars, as well as educating patients. Interested parties can contact Sheila Brown at sheila.brown1@fda.hhs.gov or Ian Weiss at ian.weiss@fda.hhs.gov for further information.
    Bruker Maldi TOF Maintenance
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Food and Drug Administration (FDA), is seeking proposals for a full-service maintenance agreement for its Bruker MALDI Biotyper Commercial Module instrument system. The contract requires comprehensive coverage for all repairs and annual preventative maintenance services, including prompt troubleshooting, immediate access to certified replacement parts, and updates from the original manufacturer, with a performance period starting January 16, 2025, and extending for five years with four additional one-year options. This maintenance is crucial for the FDA's mission to monitor antimicrobial resistance in foodborne and zoonotic pathogens, ensuring the instrument operates according to manufacturer specifications. Interested vendors must submit their proposals by 11:59 AM EST on January 21, 2025, and can contact James O’Keefe at 301-796-7371 or via email at James.OKeefeIII@fda.hhs.gov for further information.